secwatch.observer — SEC 8-K summary
======================================

Issuer:     TFF Pharmaceuticals, Inc. (—)
CIK:        0001733413
Form:       8-K
Filed at:   2024-12-10T23:59:59+00:00
Accession:  0001213900-24-107409
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TFF Pharmaceuticals receives Nasdaq delisting notice; trading to suspend Dec 13
-------------------------------------------------------------------------------

- On Dec 4, 2024, Nasdaq notified TFFP of delisting based on Plan of Dissolution, public interest concerns, and listing compliance issues.
- Trading of TFFP common stock will be suspended at the opening of business on December 13, 2024.
- Nasdaq will file Form 25-NSE with the SEC to remove the securities from listing and registration.
- Company states it does not intend to appeal the delisting determination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733413/000121390024107409/0001213900-24-107409-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733413/000121390024107409/ea0224167-8k_tffpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-107409

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer